SIRT1 and myeloid sarcoma: Although pervious experiments in MS patients, as most close disease to NMO, displayed an elevated level of SIRT1 in the plasma and a decreased level of this protein in PBMCs of MS patients [43,44], our investigation didn’t show any changes in the level of this protein during NMO disease.